Red Light Holland has received an official Certificate of Analysis (COA) through its research and development partner, Irvine Labs Inc., California, USA, confirming psilocybin potency and process validation for potential medical grade manufacturing applications.
The testing was conducted on Red Light Holland's naturally derived psilocybin truffles from its Netherlands facility, which were successfully shipped to the FDA-compliant and DEA-registered Irvine Labs facility in California, USA. Results confirm the materials are compatible with manufacturing processes being developed for potential medical grade applications.
Red Light Holland and Irvine Labs continue to advance proprietary dehydration and packaging processes designed to extend shelf life while maintaining product integrity.
Red Light Holland is also preparing for the next and larger planned psilocybin export under Irvine Labs existing 2025 DEA quota allocation.
This validation represents significant progress in the partnership between Red Light Holland and Irvine Labs as they work toward developing standardized psilocybin products aimed for emerging therapeutic markets, government-funded pilot programs, and clinical trials.
For more information:
Red Light Holland
redlight.co
